Brainstorm Cell Therapeutics And Pluri Partner To Support Nurown® Phase 3B Trial Manufacturing
Memorandum of Understanding has been signed NEW YORK, Nov. 11, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc ...
manilatimes2d
Fate Therapeutics Presents Pan-tumor Targeting Preclinical Data for FT836 MICA/B-targeted CAR T-cell Product Candidate at 2024 SITC Annual Meeting
The expression of MICA/B cell-surface proteins is induced by cellular stress ... or other attributes to warrant further ...
eLife2d
MuSK-BMP signaling in adult muscle stem cells maintains quiescence and regulates myofiber size
A central question in adult stem cell biology is elucidating the signaling pathways regulating their dynamics and function in diverse physiological and age-related contexts. Muscle stem cells in ...
eLife3d
An altered cell-specific subcellular distribution of translesion synthesis DNA polymerase kappa (POLK) in aging neurons
POLK expression in neurons and report an important observation that POLK exhibits an age-dependent change in subcellular localization, from the nucleus in young tissue to the cytoplasm in old tissue.
BeiGene: TEVIMBRA European Push Continues With Positive CHMP Opinion
BeiGene's TEVIMBRA expands for cancer treatment, and BRUKINSA sales soar 107%. See why BGNE stock presents upside potential ...
manilatimes6d
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
CASGEVY has received regulatory approvals for the treatment of patients 12 ... in relapsed or refractory (r/r) CD19-positive ...
Antibody-based treatment for the most aggressive type of breast cancer could also treat other cancers
In a study published in Cell Reports, researchers from Prof. Idit Shachar's laboratory at the Weizmann Institute of Science ...